CS

Chandrasekar Sathish Kumar

Active Director Director DIN 10396147
DIN 10396147 First appointment Nov 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Chandrasekar Sathish Kumar

Data last updated:

Chandrasekar Sathish Kumar is a Director at Wisemen Life Sciences Private Limited (since 2023). Wisemen Life Sciences Private Limited reported revenue of ₹28,840 (FY 2024).

DIN 10396147
Primary Designation Director
First Appointment 18 Nov 2023
Oldest Company Age 2 yrs
Largest company Wisemen Life Sciences Private Limited · ₹28,840 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Nov 20232023₹28,840 (FY 2024)Active

Board colleagues of Chandrasekar Sathish Kumar

Directorship timeline

Open interactive timeline →
Wisemen Life Sciences Private Limited
Premium access

Shareholding and investment profile for Chandrasekar Sathish Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandrasekar Sathish Kumar

Chandrasekar Sathish Kumar currently holds 1 directorship: Wisemen Life Sciences Private Limited (Director, since 18 Nov 2023, revenue ₹28,840 (FY 2024)).

Chandrasekar Sathish Kumar was first appointed on 18 Nov 2023 as Director at Wisemen Life Sciences Private Limited.

The current boards of Chandrasekar Sathish Kumar's companies include Kannammal (Wisemen Life Sciences Private Limited), Pravin (Wisemen Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available